90 related articles for article (PubMed ID: 43210)
21. A new sensitive method which unlike the Vogel test detects the anxiolytic effect of tofisopam.
Miklya I; Knoll J
Pol J Pharmacol Pharm; 1988; 40(6):561-72. PubMed ID: 2908362
[TBL] [Abstract][Full Text] [Related]
22. Effects of diazepam and zolpidem on EEG beta frequencies are behavior-specific in rats.
van Lier H; Drinkenburg WH; van Eeten YJ; Coenen AM
Neuropharmacology; 2004 Aug; 47(2):163-74. PubMed ID: 15223295
[TBL] [Abstract][Full Text] [Related]
23. Opioid benzodiazepine tifluadom and drug-induced hyperactivity in mice: lack of benzodiazepine-like effects.
Sansone M; Castellano C; Pavone F; Hano J
Pol J Pharmacol Pharm; 1985; 37(5):585-90. PubMed ID: 2870483
[TBL] [Abstract][Full Text] [Related]
24. [Behavioral and electrophysiologic analysis of the anxiolytic effect of astragalus mongolian].
Molodavkin GM; Aldarmaa Zh; Voronina TA; Davgatsérén B
Biull Eksp Biol Med; 1998 Apr; 125(4):407-9. PubMed ID: 9631722
[No Abstract] [Full Text] [Related]
25. [Anxiolytic drugs and inhibition].
Zarifian E
Encephale; 1978; 4(5 Suppl):547-51. PubMed ID: 38106
[TBL] [Abstract][Full Text] [Related]
26. The validation of animal tests of anxiety--pharmacological implications.
File SE
Pol J Pharmacol Pharm; 1984; 36(5):505-12. PubMed ID: 6152493
[TBL] [Abstract][Full Text] [Related]
27. Behavioral effects of nonbenzodiazepine anxiolytic drugs: a comparison of CGS 9896 and zopiclone with chlordiazepoxide.
Sanger DJ; Joly D; Zivkovic B
J Pharmacol Exp Ther; 1985 Mar; 232(3):831-7. PubMed ID: 2857789
[TBL] [Abstract][Full Text] [Related]
28. Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models.
Engin E; Treit D; Dickson CT
Neuroscience; 2009 Jun; 161(2):359-69. PubMed ID: 19321151
[TBL] [Abstract][Full Text] [Related]
29. The anxioselective agent 7-(2-chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) is more efficacious than diazepam at enhancing GABA-gated currents at alpha1 subunit-containing GABAA receptors.
Popik P; Kostakis E; Krawczyk M; Nowak G; Szewczyk B; Krieter P; Chen Z; Russek SJ; Gibbs TT; Farb DH; Skolnick P; Lippa AS; Basile AS
J Pharmacol Exp Ther; 2006 Dec; 319(3):1244-52. PubMed ID: 16971504
[TBL] [Abstract][Full Text] [Related]
30. [The anxiolytic activity of calcium-channel blockers in tests of anxious behavior in mice and rats].
Kozlovskiĭ VL
Zh Vyssh Nerv Deiat Im I P Pavlova; 1999; 49(1):84-95. PubMed ID: 10330709
[TBL] [Abstract][Full Text] [Related]
31. [Effect of typical and atypical anxiolytics on the behavior and electrophysiological parameters of rats with model cerebrovascular pathology].
Molodavkin GM; Cadikov MK; Voronina TA; Sadikova ZU; Meletova OK; Pchelkina MI; Larentsova LI; Gan'shina TS; Mirzoian RS
Eksp Klin Farmakol; 2004; 67(6):16-9. PubMed ID: 15707007
[TBL] [Abstract][Full Text] [Related]
32. GABA A receptor subtype selectivity underlying selective anxiolytic effect of baicalin.
Wang F; Xu Z; Ren L; Tsang SY; Xue H
Neuropharmacology; 2008 Dec; 55(7):1231-7. PubMed ID: 18723037
[TBL] [Abstract][Full Text] [Related]
33. Influence of ethylalcohol on the effect of benzodiazepines in rats and mice.
Zácková P; Zamazalová I; Láznícek M
Act Nerv Super (Praha); 1978 Dec; 20(4):242-4. PubMed ID: 32722
[No Abstract] [Full Text] [Related]
34. Comparative behavioural effects of benzodiazepine and non-benzodiazepine anxiolytics in rhesus monkeys.
Kumar R; Palit G; Singh JR; Dhawan BN
Pharmacol Res; 1999 Jun; 39(6):437-44. PubMed ID: 10373237
[TBL] [Abstract][Full Text] [Related]
35. Drug therapy. Benzodiazepines (first of two parts).
Greenblatt DJ; Shader RI
N Engl J Med; 1974 Nov; 291(19):1011-5. PubMed ID: 4153318
[No Abstract] [Full Text] [Related]
36. Pharmacological activities of clobazam and diazepam in the rat: relation to drug brain levels.
Caccia S; Carli M; Garattini S; Poggesi E; Rech R; Samanin R
Arch Int Pharmacodyn Ther; 1980 Feb; 243(2):275-83. PubMed ID: 6103693
[TBL] [Abstract][Full Text] [Related]
37. Neuropharmacology of a new potential anxiolytic compound, F 2692, 1-(3'-trifluoromethyl phenyl) 1,4-dihydro 3-amino 4-oxo 6-methyl pyridazine. 1. Acute and in vitro effects.
Assié MB; Chopin P; Stenger A; Palmier C; Briley M
Psychopharmacology (Berl); 1993; 110(1-2):13-8. PubMed ID: 7870872
[TBL] [Abstract][Full Text] [Related]
38. Non-benzodiazepine anxiolytics: potential activity of phenylpiperazines without 3H-diazepam displacing action.
Lloyd KG; Depoortere H; Scatton B; Schoemaker H; Zivkovic B; Manoury P; Langer SZ; Morselli PL; Bartholini G
Pharmacol Biochem Behav; 1985 Oct; 23(4):645-52. PubMed ID: 2866545
[TBL] [Abstract][Full Text] [Related]
39. An animal model for measuring behavioral responses to anxiogenic and anxiolytic manipulations.
Stout JC; Weiss JM
Pharmacol Biochem Behav; 1994 Mar; 47(3):459-65. PubMed ID: 7911574
[TBL] [Abstract][Full Text] [Related]
40. [Comparative evaluation of epiphyseal melatonin and benzodiazepine anxiolytics].
Arushanian ÉB
Eksp Klin Farmakol; 2012; 75(3):35-40. PubMed ID: 22679752
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
